Indivior PLC (LSE:INDV) - Share price - Overview

Stock Report

Indivior PLC INDV

Last Price
GBX332.00

Day Change
5.00|1.53%

As of 27/04/2017
17:10:02 BST | GBX
Minimum 15 Minutes Delay.

Last Close327.00p
Day Range325.30 - 332.20
Mkt Cap2.39Bil
52-Wk Range136.00 - 382.30
Yield %2.20
ISINGB00BRS65X63
Volume1,350,286
P/E12.95
P/S3.05
P/CF7.93

Share Price

Total Returns -

 Chg (%)  
More ...
Indivior PLC- 
 
Financials
201420152016
More ...
Income Statement
Turnover678.46663.69783.77
Operating Profit341.97226.47110.38
Net Profit245.22149.2325.93
Reported EPS34.0820.293.70
Balance Sheet
Current Assets363.00489.18801.20
Non Current Assets116.93146.55177.24
Total Assets479.93635.73978.43
Current Liabilities296.83409.12833.57
Total Liabilities785.11825.021,217.17
Total Equity-305.18-189.29-238.74
Cash Flow
Operating Cash Flow303.63323.99379.29
Net Change in Cash197.1594.91166.68
Broker Forecasts
Year EndingPre-taxEPSEPSgP/EPEGDPSYld %
More ...
'Broker Forecasts' provides consensus figures based on several brokers' views
2017258.3726.141.9712.706.44--
2018264.4826.802.5412.394.87--
Director Dealings
TradedActionNotifierPriceAmountValue
More ...
24/02/2017PurchaseMs. Liz Zlatkus341.606962,378.00
24/02/2017PurchaseDr. Yvonne Greenstreet341.601,4194,847.00
24/02/2017PurchaseMs. Lorna Parker341.601,2314,205.00
24/02/2017PurchaseMr. Daniel Phelan341.602,0697,068.00

Company Profile

Indivior PLC is a pharmaceutical company. The Company is engaged in the development, manufacture and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence.

Sector

Drug Manufacturers - Specialty & Generic

Market Position

173 of 1850 Companies

Index

FTSE 250 ,FTSE 350 ,FTSE All Share

Outlook

(23/02/2017) no outlook statement

Next Event 03/05/2017

Next Q1 announcement
Ratios
CompSecMkt
More ...
PER (E)12.6014.0416.18
Div Yld (E)0.003.844.14
PEG (E)5.840.341.14
ROCE166.35180.19-75.20
Op Mrgn33.84-6.91-101.32
EPS Grwth2.1668.0328.17
Dividends
PreviousLatest
More ...
Record Date18/09/1517/06/16
Ex-Div17/09/1516/06/16
Paid23/10/1529/07/16
Amnt2.087.30

Broker Sentiment

Strong Buy0
Buy1
Hold1
Sell0
Strong Sell0
  • Strong Sell
  • Strong Buy
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
More ...
Disclaimer
Directors
More ...
ChairmanMr. Howard Pien
Chief Executive OfficerMr. Shaun Thaxter
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at Trafford House, Chester Road, Manchester M32 0RS. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2017 Morningstar. All rights reserved.